loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people..

the school in yarmouth that year had a low opt-out rate � 2 percent, the superintendent said � so there was a cap on the amount of disruption an illness could cause..

october 2011  (20)..

elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital..